key: cord-0833539-8902mgly
authors: Kostakis, Ina; Smith, Gary B.; Prytherch, David; Meredith, Paul; Price, Connor; Chauhan, Anoop
title: The performance of the National Early Warning Score and National Early Warning Score 2 in hospitalised patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
date: 2020-11-08
journal: Resuscitation
DOI: 10.1016/j.resuscitation.2020.10.039
sha: 7f1f19d26f396bb7f7aa7e69917b95cdf7dc13e7
doc_id: 833539
cord_uid: 8902mgly

INTRODUCTION: Since the introduction of the UK’s National Early Warning Score (NEWS) and its modification, NEWS2, Coronavirus disease 2019 (COVID-19), has caused a worldwide pandemic. NEWS and NEWS2 have good predictive abilities in patients with other infections and sepsis, however there is little evidence of their performance in COVID-19. METHODS: Using receiver-operating characteristics analyses, we used the area under the receiver operating characteristic (AUROC) curve to evaluate the performance of NEWS or NEWS2 to discriminate the combined outcome of either death or intensive care unit (ICU) admission within 24 h of a vital sign set in five cohorts (COVID-19 POSITIVE, n = 405; COVID-19 NOT DETECTED, n = 1716; COVID-19 NOT TESTED, n = 2686; CONTROL 2018, n = 6273; CONTROL 2019, n = 6523). RESULTS: The AUROC values for NEWS or NEWS2 for the combined outcome were: COVID-19 POSITIVE, 0.882 (0.868−0.895); COVID-19 NOT DETECTED, 0.875 (0.861−0.89); COVID-19 NOT TESTED, 0.876 (0.85−0.902); CONTROL 2018, 0.894 (0.884−0.904); CONTROL 2019, 0.842 (0.829−0.855). CONCLUSIONS: The finding that NEWS or NEWS2 performance was good and similar in all five cohorts (range = 0.842−0.894) suggests that amendments to NEWS or NEWS2, such as the addition of new covariates or the need to change the weighting of existing parameters, are unnecessary when evaluating patients with COVID-19. Our results support the national and international recommendations for the use of NEWS or NEWS2 for the assessment of acute-illness severity in patients with COVID-19.

The National Early Warning Score 1 (NEWS) and its modification, NEWS2 2 , are validated for the identification of patient deterioration in a range of clinical conditions and settings. [3] [4] [5] [6] [7] [8] [9] [10] Both scores are advocated as screening tools for sepsis, 2, [11] [12] [13] performing better than the quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) score 14-17 -a bedside prompt for identifying patients with suspected infection and a high risk of poor outcomes. 18 19, 20 whilst the National Institute for Health Care and Excellence (NICE) states that it may be useful for predicting the risk of clinical deterioration in COVID-19 pneumonia in the community. 21 COVID-19 has a variable clinical presentation on a spectrum from asymptomatic carriage to lifethreatening organ dysfunction. 22 Many of its clinical features appear to be similar to those seen in other infections, e.g. increased respiratory rate, raised temperature and low systolic blood pressure, 23, 24 making the use of either NEWS or NEWS2 appear attractive for screening or monitoring in COVID- 19 .

The aim of this study was to evaluate the ability of NEWS or NEWS2 to discriminate the combined outcome of either death or intensive care unit (ICU) admission within 24 h of a vital sign set in five patient cohortsa COVID-19 positive cohort and four control cohorts (one from 2018, one from 2019 and two from 2020).

The study took place in a large NHS 25 running in handheld devices. (Note: The Learning Clinic was acquired by System C Healthcare Limited in 2015 and the Vitalpac product is now marketed within CareFlow Vitals). The software demands that each dataset contains the following: date/time of observation set (automatically recorded by Vitalpac); pulse rate (HR); breathing rate (RR); systolic blood pressure (sBP), body temperature (T); neurological status using either the Alert-Verbal-Painful-Unresponsive (AVPU) scale; and peripheral oxygen saturation (SpO2). A record of the inspired gas (i.e., air or oxygen) being breathed by the patient at the time of SpO2 measurement was also recorded in Vitalpac, as was the patient's target SpO2 range, which established the correct NEWS2 SpO2 weighting scale for the patient. 2 The Vitalpac software has embedded upper/lower limit rules to ensure that highly or extremely abnormal physiological values (out-of-range values) are only accepted after staff have been advised to check the validity of the submitted data and have been given the opportunity to modify the data originally entered. Vitalpac is used throughout the hospital's general wards but not in the maternity unit or intensive care unit.

Up until 05/02/19, the original version of NEWS 1 was deployed within Vitalpac. Thereafter, the 2017 modification of NEWS, NEWS2, 2 was implemented as handheld devices were updated. NEWS or On 04/05/2020, we extracted a database of vital sign sets for consecutive adults (>16 years) admitted to Portsmouth Hospitals University NHS Trust (PHT) between 01/01/18 and 04/05/20, inclusive. The following were excluded: (a) data from patients discharged alive from hospital before midnight on the day of admission, (b) vital sign sets where measurements were outside the following limits: SpO2 50-100%; temperature 30-42 o C; pulse/heart rate 30-200 bpm; sBP 0-300 mmHg; respiratory rate 0-70 bpm, and (c) vital sign sets for which one or more parameter measurements were missing (because a full set of data is required to calculate NEWS and NEWS2 values). Additionally, in the current analysis, patients transferred directly at admission to a critical care area and those with no vital sign sets within the last 24 h before the primary outcome were also excluded.

We studied five admission cohorts, based on the finding that the first reverse-transcriptasepolymerase-chain-reaction (RT-PCR) test that was positive for SARS-CoV-2 for an inpatient in the study hospital was sampled on 11/03/2020: The primary outcome studied was the combination of death or intensive care unit (ICU) admission within 24 h of a vital sign set. These were identified from the hospital's patient administration system (PAS) and the ICU admission database, respectively.

All data were stored in Microsoft SQL Server 2019, and analysed using R v3.6.0 statistical computing and graphics software. 26 Descriptive statistics were calculated including counts, means (+ SD), medians (IQR, Q1-Q3) and

proportions. Proportions were compared using the chi squared test with Bonferroni correction for multiple comparisons. Mean values were compared with one-way ANOVA and Scheffe's test, and median values were compared using Kruskal-Wallis and Dunn's test (Bonferroni correction).

Analyses were undertaken using either NEWS or NEWS2 values, whichever was provided by Vitalpac. Using the area under the receiver-operating characteristics (AUROC) curve, 27 we evaluated the ability of NEWS or NEWS2 to discriminate the combination of death or ICU admission within 24 h of a vital sign set in the each of the five cohorts previously described. We considered AUROC values of 0.700 to 0.800 to represent 'reasonable' discrimination; AUROC values exceeding 0.800 were considered to represent 'good' discrimination.

After exclusions, the main data extract for the period 01/01/2018 to 04/05/20 contained 2867313 vital sign sets from 97669 admissions (60436 discrete patients). Figure 1 shows the development of the datasets for each of the five study cohorts (COVID-19 POSITIVE, COVID-19 NOT DETECTED, COVID-19 NOT TESTED, CONTROL 2018 and CONTROL 2019) and Table 1 NOT DETECTED cohorts were older than in the others (<0.001). Those in the COVID-19 POSITIVE cohort were also more likely to be male (<0.001). There were also significant differences in some of the vital signs (notably, higher median RR and mean temperature, and lower median SpO2) and a higher median EWS during the stay. More patients in the COVID-19 POSITIVE cohort received supplemental oxygen whilst in-hospital (<0.001). The results also demonstrate that admissions in the COVID-19 POSITIVE cohort were older than in the other groups and more likely to be male, which appear to be common findings in COVID- 19. 22 Vital sign values were also more abnormal in this cohort, the EWS quartiles were higher and more patients received oxygen therapy.

In the CONTROL 2019 cohort we found an AUROC value of 0.842 (0.829-0.855), which is significantly lower than all other cohorts except the COVID-19 NOT TESTED cohort. Given the limited demographic data available to us and the pattern of the AUROC values across the period 01/01/18 -31/12/19 (Figure 4) , we believe that this could reflect the influence of differing pressures on clinical services. However, it is also possible that the change from NEWS to NEWS2 from 06/02/19 onwards may have contributed, as particular elements of implementing NEWS2, including the use of a specific scale for use in patients with hypercapnic respiratory failure, have proven challenging. 28 Interestingly, the AUROC value for the COVID-19 NOT DETECTED cohort was the same as that for the COVID-19 POSITIVE group of admissions. However, the percentage of observation sets followed by the combined outcome in the COVID-19 NOT DETECTED cohort was half that in the COVID-19 POSITIVE cohort. In most cases in the COVID-19 NOT DETECTED cohort, the RT-PCR test was performed on the basis of symptoms and signs, and a presumed diagnosis of COVID-19 infection.

However, the high false negative rate observed for RT-PCR tests for SARS-CoV-2 29 could mean that many of the patients in the COVID-19 NOT DETECTED cohort were actually positive for COVID-19

infection. Perhaps a lower viral load in the COVID-19 NOT DETECTED cohort leads to a lower chance of SARS-CoV-2 detection and a lower risk of the combined outcome. 30 

Major strengths of this study are that it considers all patient admissions to the study hospital during the first two months of the COVID-19 outbreak. It draws upon a large dataset of vital signs collected simultaneously in a standardized manner during clinical care using an electronic data collecting system. It also considers a repeatable, clinically and operationally useful, objective combined outcome, for which data were easily retrievable from the hospital's electronic records.

However, there are also weaknesses. The RT-PCR test for SARS-CoV-2 is not 100% accurate and negative results need to be interpreted with caution. 22, 29 Therefore, as mentioned earlier, there is a risk that the COVID-19 NOT DETECTED cohort may have been contaminated by false-negative test results. In addition, there is also a chance, albeit much smaller, that the COVID-19 POSITIVE cohort We excluded admissions that were admitted directly to critical care areas of the hospital. Our logically necessary exclusion of all those with no vital sign sets in the last 24 h also had the effect of removing any patient on an End-of-Life (EoL) pathway where vital sign monitoring had ceased. We obtained the patient's date and time of death and/or ICU admission from the hospital's PAS and ICU admission database, respectively. These data are likely to be systematically late, implying that the number of observations followed by the combined outcome may be an underestimate.

This is a single centre study such that the results are not necessarily transferrable and require external validation. We used repeated observation sets from the same patient episode in the analysis, making the assumption that the observation sets are independent based on previous work by our group. 31 The conclusions of our work are also based on the assumption that all patients were treated optimally and equitably. A further weakness is that the study was conducted in a single site, where the precursor of NEWS -ViEWS 32 -was developed. Prediction models are almost always more accurate in the population in which they were derived. Finally, this is a statistical evaluation of NEWS or Our study provides data from a large cohort of unselected hospital admissions and focuses on an outcome measure that is both clinically relevant and has the potential to be averted with the appropriate and timely clinical intervention. Unlike other journal publications, [33] [34] [35] [36] [37] it uses NEWS and NEWS2 values from the whole hospital admission and compares the performance of the scores in patients who had a positive RT-PCR test result for SARS-CoV-2 with several other patient groups in the same hospital that were, as far as can be determined, not suffering from a COVID-19 illness. This has permitted an assessment of the need for any amendment to NEWS or NEWS2, such as the addition of age 34, 38 or other covariates or a change in the weighting of existing parameters, 39 when evaluating patients with COVID-19. The finding that NEWS or NEWS2 performance was good and similar in all five cohorts (range = 0.842-0.894) suggests that such changes are unnecessary and supports the continued use of NEWS or NEWS2 role as systems for the assessment of acute-illness severity in hospitalised patients irrespective of the underlying condition. [3] [4] [5] [6] [7] [8] [9] [10] In addition, the results demonstrate that NEWS and NEWS2 remain highly relevant for illness severity assessment, even for J o u r n a l P r e -p r o o f patients suffering a completely novel disease that has emerged some years after the two scoring systems were developed. Previous research into the performance of NEWS or NEWS2 for 24 h outcomes shows similar AUROC values to those found in the current study. [2] [3] [4] [5] [6] 13, 15 Consequently, our results support the continued adherence to the national and international guidance on the use of the systems in patients with COVID-19. [20] [21] [22] Of course, demonstration that NEWS and NEWS2 discriminate adverse outcomes well does not imply that the important, but separate, issues of when and how care is escalated may not require modification. 40 The results of our study require validation, if possible, in a larger population. In addition, future research could investigate the hypothesis that, because both NEWS and NEWS2 use a binary weighting for oxygen supplementation [air = 0, oxygen = 2 points], they might not detect sudden and rapid respiratory decompensation if a patient who is already receiving supplemental oxygen develops a rapid increase in oxygen requirement without additional changes in other physiological parameters. 19 

The finding that NEWS or NEWS2 performance was good and similar in all five cohorts (range = 0.842-0.894) suggests that amendments to NEWS or NEWS2, such as the addition of new covariates or the need to change the weighting of existing parameters, are unnecessary when evaluating patients with COVID-19. Our results support the national and international recommendations for the use of NEWS or NEWS2 for the assessment of acute-illness severity in patients with COVID-19. <0.00 1 HR = heart/pulse rate; RR= respiratory rate; sBP = systolic blood pressure SpO2 = peripheral oxygen saturation; NEWS, National Early Warning Score; NEWS2, National Early Warning Score 2. Count data has been tested for significance using Fisher's exact test with Bonferroni correction for pairwise comparison. Percentages were compared using the chi squared test with Bonferroni correction. Mean values were compared with one-way ANOVA and Scheffe's test Median values were compared using Kruskal-Wallis and Dunn's test (Bonferroni correction). IQR = Interquartile range (Q1-Q3)

Standardising the assessment of acute-illness severity in the NHS

National Early Warning Score (NEWS) 2. Standardising the assessment of acute-illness severity in the NHS. Updated report of a working party

The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death

National Early Warning Score Accurately Discriminates Risk of Serious Adverse Events in Patients with Liver Disease

A comparison of the ability of the National Early Warning Score and the National Early Warning Score 2 to identify patients at risk of in-hospital mortality: A multi-centre database study

Comparison of the National Early Warning Score in non-elective medical and surgical patients

Association between National Early Warning Scores in primary care and clinical outcomes: an observational study in UK primary and secondary care

Use of the National Early Warning Score for predicting in-hospital mortality in older adults admitted to the emergency department

The National Early Warning Score: Translation, testing and prediction in a Swedish setting

National early warning score (NEWS) in a Finnish multidisciplinary emergency department and direct vs. late admission to intensive care

Utility of a single early warning score in patients with sepsis in the emergency department

Cook A for the West of England Patient Safety Collaborative. Implementation of the National Early Warning Score in patients with suspicion of sepsis: evaluation of a system-wide quality improvement project

Use of the National Early Warning Score (NEWS) to Identify Acutely Deteriorating Patients with Sepsis in Acute Medical Ward

A comparison of the quick Sequential [Sepsis-related] Organ Failure Assessment score and the National Early Warning Score in non-ICU patients with/without infection

NEWS2 Is Superior to qSOFA in Detecting Sepsis with Organ Dysfunction in the Emergency Department

Superior performance of National Early Warning Score compared with quick Sepsis-related Organ Failure Assessment Score in predicting adverse outcomes: a retrospective observational study of patients in the prehospital setting

Comparison of SIRS, qSOFA, and NEWS for the early identification of sepsis in the Emergency Department

The third international consensus definitions for sepsis and septic shock (Sepsis-3)

Royal College of Physicians. NEWS2 and deterioration in COVID-19

clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected

COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community

Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19). A Review

Clinical Course and Risk Factors for Mortality of Adult Inpatients With COVID-19 in Wuhan, China: A Retrospective Cohort Study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Hospital-wide physiological surveillance -a new approach to the early identification and management of the sick patient

R: A language and environment for statistical computing. R Foundation for Statistical Computing

The meaning and use of the area under a receiver operating characteristic (ROC) curve

National Early Warning Score (NEWS) 2. Standardising the assessment of acute-illness severity in the NHS. Additional implementation guidance Update

False Negative Tests for SARS-CoV-2 Infection -Challenges and Implications

Viral dynamics in mild and severe cases of COVID-19

Are vital signs sets independent? Effects of observation selection methods on early warning score performance

ViEWS -towards a national early warning score for detecting adult inpatient deterioration

Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection

NEWS can predict deterioration of patients with COVID-19

Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores

Evaluation of the Risk Prediction Tools for Patients With Coronavirus Disease 2019 in Wuhan, China. A Single-Centered, Retrospective, Observational Study

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China

NEWS2 system requires modification to identify deteriorating patients with COVID-19

Early warning scores: unravelling detection and escalation

Distribution of NEWS or NEWS2 values for the five admission cohorts